Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injury
Main Authors: | Alexander G Rabchevsky, Samir P Patel, Patrick G Sullivan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2017;volume=12;issue=11;spage=1807;epage=1808;aulast=Rabchevsky |
Similar Items
-
Interactions between mitoNEET and NAF-1 in cells.
by: Ola Karmi, et al.
Published: (2017-01-01) -
The Mitochondrial Protein MitoNEET as a Probe for the Allostery of Glutamate Dehydrogenase
by: Chimere Nnatubeugo, et al.
Published: (2022-11-01) -
Inhibition of mitoNEET attenuates LPS-induced inflammation and oxidative stress
by: Seunghee Lee, et al.
Published: (2022-02-01) -
MitoNEET Provides Cardioprotection via Reducing Oxidative Damage and Conserving Mitochondrial Function
by: Eddie Tam, et al.
Published: (2023-12-01) -
Biochemical control of the mitochondrial protein MitoNEET by biological thiols and lipid-derived electrophiles
by: R.A. Skolik, et al.
Published: (2023-04-01)